Go Back
SNIPR Biome
SNIPR Biome is pioneering a novel use of CRISPR/Cas technology for microbial gene therapy. Our focus is on the development of novel, highly selective anti-bacterial drug candidates for use in difficult-to-treat conditions.
More Details
Our CRISPR-based technology can very precisely target specific “bad” bacteria in the gut without affecting the “good” bacteria of the resident microbiota.
This platform leverages two naturally derived technologies that originated in bacteria (bacteriophages for delivery, CRISPR/Cas for killing), both of which create an advantage in terms of selectively targeting specific bacterial species.